Additionally, preliminary studies from our lab showed that physiological (low) doses of TSLP increased STAT5, AKT, and S6 phosphorylation and contributed to CRLF2 B-ALL cell survival [29]. The gene discussed is CRLF2; the disease is precursor B-cell acute lymphoblastic leukemia.